Hafer Nathaniel, Keenan Christian, Deb Anindita
UMass Center for Clinical and Translational Science, UMass Chan Medical School, Worcester, MA, US.
Program in Molecular Medicine, UMass Chan Medical School, Worcester, MA, US.
J Clin Transl Sci. 2025 Jul 24;9(1):e172. doi: 10.1017/cts.2025.10112. eCollection 2025.
New educational curricula are emerging to train physicians for healthcare in the 21 century. The University of Massachusetts Chan Medical School T.H. Chan School of Medicine (UMass Chan) implemented an MD curriculum redesign in the fall of 2022 that included seven educational pathways, including Entrepreneurship, Biomedical Innovation, and Design. This new pathway curriculum introduces students to the principles of innovation, entrepreneurship, basic engineering principles, and technology commercialization. It is modeled after the I-Corps curriculum with added material regarding engineering principles. I-Corps was initially developed by the National Science Foundation (NSF) to help scientists understand the commercial potential of their inventions. Major elements include the Business Model Canvas and Customer Discovery [19-22]. First-year (Class of 2027) and second-year (Class of 2026) pathway students were invited to participate in online surveys evaluating course material and their knowledge of course content. Initial results show that the program was well received and student self-assessment demonstrated significant improvement. Objective student knowledge also significantly improved. Novel curricula have the potential to transform medical education and prepare future physicians to practice healthcare in the 21 Century.
新的教育课程正在涌现,以培养21世纪从事医疗保健工作的医生。马萨诸塞大学医学院陈曾熙医学院(UMass Chan)于2022年秋季实施了医学博士课程重新设计,其中包括七条教育途径,包括创业、生物医学创新和设计。这条新的途径课程向学生介绍创新、创业、基础工程原理和技术商业化的原则。它以创新团队(I-Corps)课程为蓝本,并添加了有关工程原理的内容。创新团队(I-Corps)最初由美国国家科学基金会(NSF)开发,以帮助科学家了解其发明的商业潜力。主要内容包括商业模式画布和客户发现[19-22]。邀请了一年级(2027届)和二年级(2026届)途径课程的学生参加在线调查,评估课程材料以及他们对课程内容的了解。初步结果表明,该项目受到好评,学生的自我评估显示有显著进步。学生的客观知识也有显著提高。新颖的课程有潜力改变医学教育,并使未来的医生能够在21世纪从事医疗保健工作。